The AI-native operating system for life sciences regulatory.
REGARA™ compresses the path from regulatory strategy to global approval — and turns the institutional knowledge each submission generates into a compounding, defensible data asset.
Bringing a new therapy or device to patients is one of the hardest, most consequential undertakings an organization can pursue. Too often, the regulatory execution layer is the reason a breakthrough arrives years late — or the reason a smaller innovator gets out-resourced into irrelevance.
Regulatory affairs sits at the intersection of scientific innovation and patient access. Yet the workflows, document templates, and tribal knowledge that govern the function have changed little in fifty years — even as approval pathways grow more complex, requirements evolve in real time across jurisdictions, and the skilled labor pool retires faster than it can be replaced.
The result is hundreds of billions in lost opportunity across the industry, and lives that go on hold while the system catches up.
REGARA™ exists to close that gap.
- 01A regulatory knowledge graph.
Spanning the world's major health authorities — FDA, EMA, PMDA, NMPA, MHRA, Health Canada, TGA, ANVISA — re-indexed daily and versioned forever.
- 02AI agents trained for regulatory work.
Purpose-built for the precise, auditable, evidence-driven nature of the discipline. Not a chatbot wrapped in a workflow.
- 03One governed environment.
Strategy generation, document drafting, compliance verification, and submission orchestration — all inside a single platform, with one audit trail.
- 04Minutes, not months — responsibly.
Every output is structured, traceable, and auditable to the standard of the receiving authority. The intelligence at the core is what makes the speed responsible.
Four convictions, written before the first line of code.
Regulatory excellence should not be the bottleneck.
Not between a breakthrough and the patients who need it. The science is the hard part. The execution layer is engineering.
No company should choose between ambition and reality.
Scientific ambition and operational reality should not be in tension. The infrastructure should let a team run the experiment its science deserves.
Institutional knowledge should compound.
The decades of submission expertise built up inside an organization should not walk out the door when a senior leader retires. It should accrete to the company that earned it.
Enterprise-grade infrastructure, for every innovator.
Every life sciences company — not just the largest — deserves regulatory infrastructure capable of competing globally.
Bring life sciences innovation to market faster.
Reducing the cost of regulatory execution, expanding the window for return on R&D, and ultimately improving and extending lives at global scale.
The regulatory infrastructure layer behind every approval in the world.
One operating system, every health authority, every life sciences company. Every approval that brings a breakthrough to a patient.
If this is the work, we want to talk to you.
Whether you're a regulatory professional, a researcher, or an engineer who wants to build the rails — we're hiring.